| 685448 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Consolidation Treatment and Long-Term Prognosis of Rituximab in Minimal Change Disease and Focal Segmental Glomerular Sclerosis |
2021-05-01 |
10.2147/dddt.s302257 |
Lin Li, Wang Weiming, Wu YiFan, Xie JingYuan, Li Xiao, Pan XiaoXia, Zhang Wen, Xu Jing, Cai YiKai, Ren Hong, Chen Nan |
| 685447 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside |
2021-05-01 |
10.2147/dddt.s251865 |
Agarwala Anandita, Quispe Renato, Goldberg Anne C, Michos Erin D |
| 685446 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Body Mass Index Influence on the Clinical Outcomes for Nonvalvular Atrial Fibrillation Patients Admitted to a Hospital Treated with Direct Oral Anticoagulants: A Retrospective Cohort Study |
2021-05-01 |
10.2147/dddt.s303219 |
Li Xiaoye, Zuo Chengchun, Ji Qiuyi, Xue Ying, Wang Zi, Lv Qianzhou |
| 685445 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Incidence and Risk Factors of Hepatic Fibrosis in Psoriatic Patients Receiving Methotrexate with Concomitant Acitretin Therapy and Methotrexate Monotherapy |
2021-05-01 |
10.2147/dddt.s304168 |
Rattanakaemakorn Ploysyne, Pinyowiwat Prinpat, Iamsumang Wimolsiri, Chanprapaph Kumutnart, Suchonwanit Poonkiat |
| 685444 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
An Integrated Analysis of Network Pharmacology, Molecular Docking, and Experiment Validation to Explore the New Candidate Active Component and Mechanism of Cuscutae Semen-Mori Fructus Coupled-Herbs in Treating Oligoasthenozoospermia |
2021-05-01 |
10.2147/dddt.s307015 |
Bai Xue, Tang Yibo, Li Qiang, Liu Dan, Liu Guimin, Fan Xiaolei, Liu Zhejun, Yu Shujun, Tang Tian, Wang Shuyan, Li Lingru, Zhou Kailin, Zheng Yanfei, Liu Zhenquan |
| 685443 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Pharmacokinetics of Linezolid Dose Adjustment for Creatinine Clearance in Critically Ill Patients: A Multicenter, Prospective, Open-Label, Observational Study |
2021-05-01 |
10.2147/dddt.s303497 |
Wang Xipei, Wang Yifan, Yao Fen, Chen Shenglong, Hou Yating, Zheng Zhijie, Luo Jinbiao, Qiu Binghui, Li Zhanfu, Wang Yirong, Wu Zheng, Lan Jinhua, Chen Chunbo |
| 685442 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Protective Effect of Lemon Peel Extract on Oxidative Stress in H9c2 Rat Heart Cell Injury |
2021-05-01 |
10.2147/dddt.s304624 |
Wang Jun, Zhai Yulin, Ou Mingguang, Bian Yunfeng, Tang Chenglong, Zhang Wanchao, Cheng Yujiao, Li Guijie |
| 685441 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Evaluating Guanfacine Hydrochloride in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adult Patients: Design, Development and Place in Therapy |
2021-05-01 |
10.2147/dddt.s221126 |
Ota Toyosaku, Yamamuro Kazuhiko, Okazaki Kosuke, Kishimoto Toshifumi |
| 685440 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
An Overview of the Efficacy and Safety of Ozanimod for the Treatment of Relapsing Multiple Sclerosis |
2021-05-01 |
10.2147/dddt.s240861 |
Fronza Marzia, Lorefice Lorena, Frau Jessica, Cocco Eleonora |
| 685439 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
FTY720 Inhibits the Development of Collagen-Induced Arthritis in Mice by Suppressing the Recruitment of CD4+ T Lymphocytes |
2021-05-01 |
10.2147/dddt.s293876 |
Zhu Chao, Wen Shuang, Li Junyong, Meng Hongyu, Zhang Junzhe, Zhao Kuo, Wang Ling, Zhang Yingze |
